Remedy Product Studio is excited to announce our investment in our new portfolio company, Sol Health.
With this investment, Remedy supports Sol Health’s mission of tackling the youth mental health crisis and providing much-needed support for the next generation of therapists.
Remedy’s investment is part of a pre-seed round led by BAM Ventures, with participation from LEAD VC, Cake Ventures, Strada Education Foundation, FullCircle Fund, Gaingels, and more.
Why We Like It
The growing mental health crisis is a two-sided problem: not only is demand for therapists increasing among young people, but there is also a supply-side shortage of mental health professionals that treat them.
At the core of this issue is a strained therapist pipeline, with 57% of therapists-in-training abandoning their careers before licensure due to inadequate pay, subpar supervision, access to clinical case hours, and limited training resources.
On the other side of the problem, 60% of Gen Z suffers from mental health issues, and care is disproportionately inaccessible compared to other demographics. College counseling centers are under-resourced, private therapists are too expensive, and in-network care is only a viable option for high-tier plans. These issues particularly impact minority groups who face additional barriers to care.
Sol health is tackling the mental health crisis from both sides.
Not only is Sol Health the first mental health company leveraging therapists-in-training to solve the clinician shortage, but it is also providing therapists with resources traditional placement sites lack — such as personalized supervision, guaranteed caseloads, and stipends — all while delivering affordable therapy to young people at $30/session.
Due to its unique business model, Sol Health also emphasizes greater diversity and Gen-Z-alignment in its therapist cohorts compared to most online platforms, enabling more effective, culturally competent care. By empowering the next generation of therapists and making therapy more accessible, Sol Health is reshaping the mental health landscape for students across the country.
Remedy’s Value Add
Through our investment, Remedy will collaborate with Sol Health to define its product vision, prioritize feature roll-out, and align the technology build with Sol Health’s overall business strategy. Specifically, Remedy will focus on building:
A modern patient platform to offer patients holistic mental health support through a web application that will support telemedicine, messaging, and patient profiles
A clinician portal with expanded functionality including an EHR platform with automated clinical flows, embedded training modules, automated communication triggers, and a dashboard for patient data visualization
B2B2C integrations with institutional payors
"When it came to our product vision, Gun and I were very intentional in finding a long-term thought partner who could understand our product across business, branding, and technical dimensions,” said Melinda Gong, Sol Health’s CPO and Co-Founder. “Remedy stood out not only for their technical expertise, agile principles, and highly organized team, but also for their proven track record, e.g. building for other health tech startups like Manatee and Caraway. We’re thrilled to have Remedy on board as we bring our vision for Sol Health to life.”
The investment in Sol Health aligns with Remedy’s thesis of investing in technology businesses that enhance personal wellbeing and improve care delivery.
“If you told me we would invest in multiple mental health companies this year, I wouldn’t believe you,” says Jess Schram, Remedy’s Director of Investments and Incubations. “But when we saw that Sol Health was solving the systemic problem of placing therapists while lowering barriers to care, it became a no-brainer. This business model is unlike anything we had seen before and Gun and Melinda are incredible builders.”
Comments